301015 百洋醫藥
按盤價 
21.720 +0.670 (+3.183%)
21.720 +0.670 (+3.183%) | 2025/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,840,875 | -0.38% | 8,094,458 | 8,255,998 | 7,509,618 | 7,051,567 | |
| 減：營業總成本 | 1,635,496 | 3.39% | 7,169,337 | 7,256,782 | 6,832,016 | 6,502,550 | |
| 其中:營業成本 | 1,181,508 | -3.62% | 5,220,660 | 5,507,152 | 5,424,874 | 5,279,724 | |
| 財務費用 | 22,480 | 84.74% | 71,109 | 65,613 | 48,385 | 61,340 | |
| 資產減值損失 | (34,186) | 3,234.60% | (16,023) | 1,911 | (1,160) | 2,596 | |
| 公允價值變動收益 | (24,154) | 8,951.14% | 1,716 | 616 | (10,750) | 5,874 | |
| 投資收益 | (8,918) | -204.03% | 59,209 | 44,591 | 1,877 | 3,900 | |
| 其中：對聯營企業和合營企業的投資收益 | (7,360) | -182.62% | 51,121 | 18,874 | 15,601 | 17,182 | |
| 營業利潤 | 145,211 | -45.68% | 977,738 | 1,043,604 | 674,258 | 561,482 | |
| 利潤總額 | 143,254 | -46.13% | 966,628 | 1,027,991 | 668,550 | 565,418 | |
| 減：所得稅費用 | 33,591 | -47.70% | 199,597 | 257,263 | 178,709 | 150,403 | |
| 淨利潤 | 109,663 | -45.64% | 767,031 | 770,728 | 489,841 | 415,016 | |
| 減：非控股權益 | 24,650 | 59.26% | 75,437 | 58,667 | (16,757) | (6,626) | |
| 股東淨利潤 | 85,013 | -54.36% | 691,593 | 712,061 | 506,598 | 421,642 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.160 | -54.29% | 1.320 | 1.360 | 0.960 | 0.850 | |
| 每股派息 (元) * | -- | -- | 0.762 | 0.762 | 0.762 | 0.667 | |
| 每股淨資產 (元) * | 4.491 | -13.67% | 4.329 | 4.887 | 4.384 | 4.107 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 23/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
